T. Rowe Price Associates’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,443
Closed -$7K 3028
2022
Q1
$7K Buy
+12,443
New +$8.9K ﹤0.01% 2969
2021
Q4
Sell
-52,243
Closed -$73K 3076
2021
Q3
$73K Sell
52,243
-19,700
-27% -$35.8K ﹤0.01% 2883
2021
Q2
$160K Buy
71,943
+1,047
+1% +$2.44K ﹤0.01% 2770
2021
Q1
$203K Buy
70,896
+59,379
+516% +$182K ﹤0.01% 2691
2020
Q4
$30K Buy
11,517
+776
+7% +$2.11K ﹤0.01% 2658
2020
Q3
$19K Buy
+10,741
New +$20.9K ﹤0.01% 2585

Other funds holding NBEV

T. Rowe Price Associates's NBEV Position: Q2 2022 in Review

T. Rowe Price Associates sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q2 2022, closing a stake of 12,443 shares — an estimated $7K sold.

T. Rowe Price Associates first reported a position in NBEV in Q3 2020 and held it in 6 quarters. The position peaked at $203K in Q1 2021. 81 funds tracked by Wall St. Rank hold NBEV as of Q2 2022.

  • T. Rowe Price Associates reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q2 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 12,443 NewAge, Inc. Common Stock (Delaware) shares in Q2 2022, an estimated $7K.
  • T. Rowe Price Associates first reported a position in NewAge, Inc. Common Stock (Delaware) in Q3 2020 and held it in 6 quarters.
  • T. Rowe Price Associates's NewAge, Inc. Common Stock (Delaware) position peaked at $203K in Q1 2021.
  • 81 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q2 2022.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.